Albert Cha - Director, Kalvista Pharmaceuticals, Inc

As of October 1, 2021


Albert Cha Net Worth

  • Net worth is estimated to be at least $372.95M
  • Owns at least 1,138,179 units of Kalvista Pharmaceuticals, Inc stock

Albert Cha Trading

  • Largest purchase of shares was 1,058,824 units , worth over $18M on September 12, 2018
  • In total has made about 10 transactions over 4 years
  • Usually trades in October, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Albert Cha Mailing Address

  • Mailing address is 505 Hamilton Avenue, Suite 200 Palo Alto CA 94301 CA

Kalvista Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
T. Andrew Crockett 2021 $556,120 $458,799 - $1,281,708 $11,400 $2,308,027
T. Andrew Crockett 2020 $556,120 $229,400 - $1,163,160 $11,882 $1,960,562
T. Andrew Crockett 2019 $505,000 $353,500 - $2,418,444 $11,000 $3,287,944
Benjamin L. Palleiko 2021 $435,000 $261,000 - $747,663 $15,850 $1,459,513
Benjamin L. Palleiko 2020 $435,000 $156,600 - $581,580 $11,900 $1,185,080
Benjamin L. Palleiko 2019 $366,000 $192,150 $527,794 $994,555 $11,000 $2,091,499
Christopher M. Yea 2021 $420,000 $252,000 - $712,060 $25,341 $1,409,401
Christopher M. Yea 2020 $420,000 $117,600 - $480,773 $25,271 $1,094,044
Christopher M. Yea 2019 $341,093 $174,596 - $891,350 $20,466 $1,427,505
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1348911/000119312521249158/d191826ddef14a.htm

Kalvista Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 6,000 units sold on November 3, 2021 by Edward Feener worth over $108.42K
  • In the last 4 years, insiders at Kalvista Pharmaceuticals, Inc sold an estimated value of $75.36M and bought an estimated value of $43.76M
  • The most active traders are Andrew Thomas Crockett, CEO,  Christopher Yea, Chief Development Officer,  and Edward Feener, Chief Scientific Officer
  • Insider trading is most common in October, with the busiest year in 2019 and 2021

KalVista Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1